MiR-377 Regulates Inflammation and Angiogenesis in Rats After Cerebral Ischemic Injury

Yiling Fan1, Shenghao Ding1, Yameng Sun1

  • 1Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.

Insights

MicroRNA-377 (miR-377) protects against ischemic brain injury by reducing inflammation and promoting blood vessel formation. Lowering miR-377 worsened stroke outcomes in rats.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Ischemic stroke is a major cause of global disability.
  • MicroRNA-377 (miR-377) is implicated in the response to ischemic injury.
  • Understanding miR-377's protective mechanisms is crucial for developing stroke therapies.

Purpose of the Study:

  • To investigate the protective mechanisms of miR-377 in rat models of ischemic brain injury.
  • To elucidate the role of miR-377 in regulating microglial activation, inflammation, and angiogenesis.

Main Methods:

  • Middle cerebral artery occlusion (MCAO) model in rats and oxygen-glucose deprivation (OGD) in vitro.
  • Measurement of cytokine levels, angiogenesis, and gene expression (EGR2, VEGF).
  • In vivo assessment using intracerebroventricular injection of miR-377 inhibitor.

Main Results:

  • miR-377 levels decreased post-MCAO and during OGD.
  • miR-377 knockdown increased pro-inflammatory cytokines and inhibited angiogenesis.
  • miR-377 targeted EGR2 and VEGF, modulating inflammation and angiogenesis.
  • Inhibition of miR-377 worsened stroke outcomes in rats.

Conclusions:

  • miR-377 exerts protective effects against ischemic brain injury.
  • miR-377 suppresses inflammation and promotes angiogenesis via EGR2 and VEGF.
  • Restoring miR-377 levels may be a therapeutic strategy for ischemic stroke.